Skip to content
  • Sunday, 26 July 2026
  • 3:36 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Long-Term Harvard Study Identifies Link Between Caffeinated Coffee and Tea Consumption and Reduced Risk of Dementia and Cognitive Decline
Neuroscience & Brain Research

Long-Term Harvard Study Identifies Link Between Caffeinated Coffee and Tea Consumption and Reduced Risk of Dementia and Cognitive Decline

Rifan Muazin Mar 26, 2026 0

In a landmark investigation spanning four decades, researchers from Mass General Brigham, the Harvard T.H. Chan School of Public Health,…

Read More
Neuroscience & Brain Research

Moderate Consumption of Caffeinated Coffee and Tea Associated with Reduced Risk of Dementia and Slower Cognitive Decline Over Four Decades

Rifan Muazin Mar 18, 2026 0

In a comprehensive longitudinal analysis that spans more than 40 years of clinical observation, researchers from Mass General Brigham, the…

Read More

Posts pagination

1 2
AI and Machine Learning Poised to Revolutionize Antibody Therapeutics, Experts Declare as Landmark Journal Collection ConcludesUC Davis Study Identifies Distinct Brain Chemical Signature in Patients with Anxiety DisordersInterleaved bond frustration in a triangular lattice antiferromagnetHigh-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ